Sir Shadi Lal (532879)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹324.15 |
| Market Cap | ₹170.53 Cr |
| P/E Ratio | 0 |
| ROCE | -153.83% |
| ROE | 11.51% |
| Dividend Yield | 0% |
| Profit Growth | -7.3% |
| Debt/Equity | — |
| Sales Growth | 37.63% |
| 52-Week Range | ₹205.95 — ₹324.15 |
| Sector | Agricultural Food & other Products |
Strengths
- Sales growth of 37.63% shows strong revenue momentum in the latest period.
- Latest quarter sales of ₹78 Cr provide meaningful revenue scale relative to the ₹171 Cr market cap.
- Trailing ROE of 11.51% suggests some past profitability, even if current earnings are weak.
- Trading at the 52-week high indicates market participants expect a cyclical recovery.
Concerns
- Latest quarterly net loss of ₹-17 Cr and negative earnings make P/E meaningless and valuation unsupportable.
- ROCE of -153.83% signals severe capital inefficiency or operating losses.
- Piotroski F-Score of 3/9 indicates poor financial health and high bankruptcy risk.
- Zero dividend yield and lack of disclosed debt, book value, and promoter data leave critical unknowns.
AI Analysis
I look for businesses I can understand, and sugar is a simple commodity business. Unfortunately, simple doesn't mean good. Sir Shadi Lal has a market cap of ₹171 Cr and trades at ₹324.15, right at the top of its 52-week range. That price already reflects hope, not proof. The P/E is 0.00 because there are no meaningful earnings; the latest quarter shows sales of ₹78 Cr but a net loss of ₹-17 Cr. A 37.63% sales growth figure is eye-catching, but profit growth is -7.30%, and the actual quarter is bleeding money. That is not growth; that is a cycle turning against the company, or worse, a business destroying capital. ROCE at -153.83% is horrifying. It means the capital employed in this business is earning deeply negative returns. The trailing ROE of 11.51% cannot comfort me when current operations are losing money. The Piotroski F-Score of 3 out of 9 signals weak financial health. There is no dividend yield, no disclosed book value, no debt-to-equity data, and no promoter holding data. In a commodity sugar business, a strong balance sheet and low costs are everything. With negative quarterly profits, weak scores, and the stock at its 52-week high, there is no margin of safety. I cannot value this business on hope. This is a cyclical sugar play, not an investment. I would need to see consistent operating profits, clearer financials, and a price that offers a cushion before I would touch it. For now, I watch and wait.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer